Oncorena aims to save human lives by transforming a natural substance into a breakthrough treatment for advanced kidney cancer.
Oncorena has raised €6.4M across 1 funding round from 2 investors, most recently a round in Dec 2021. Based in Lund, Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-24 | Other | €6.4M |
| Fåhraeus Startup and Growth,HealthCap |
| View deal → |
